Clinicopathological significance of PSF3 expression in uterine endometrial carcinomas
PSF3 (Partner of SLD Five 3) is a member of the heterotetrameric complex termed GINS. Previous studies have shown that PSF3 is up-regulated in several cancers and is associated with tumor malignancy. However, the clinicopathological significance of PSF3 expression in endometrial lesions is still poorly understood. To investigate whether PSF3 could serve as a useful biomarker for endometrial carcinomas, we performed immunohistochemical analysis of PSF3 expression. In 155 cases of endometrial carcinomas (ECs), the mean tumor proportion score (TPS) of PSF3 expression was 30.7% in G1 endometrioid carcinoma, 55.0% in G2 endometrioid carcinoma, 59.0% in G3 endometrioid carcinoma, and 58.9% in non-endometrioid carcinomas.
Source: Human Pathology - Category: Pathology Authors: Jong Kun Park, Noriyuki Otsuka, Utano Tomaru, Hiroaki Suzuki, Manabu Azuma, Kazuhira Okamoto, Katsushige Yamashiro, Masanori Kasahara Tags: Original Contributions Source Type: research
More News: Cancer | Cancer & Oncology | Cancer of the Uterus | Carcinoma | Endometrial Cancer | Pathology | Study